MedPage Today on MSN
High-Flow Oxygen's Survival Benefit Debunked in Respiratory Failure
Large randomized trial "recalibrates expectations," experts say ...
Gossamer Bio, Inc. (NASDAQ:GOSS) is included in our list of the 10 most active penny stocks to buy. As of March 16, 2026, ...
More than 40% of older adults experienced more than one impairment in instrumental activities of living six months after elective noncardiac surgery, according to a March study published in JAMA ...
1. The introduction of HotSwap (TM) by CytoSorbents -- The New CytoSorb exchange system 2. The renewal of its long-standing partnership with Aferetica Srl in Italy, and 3. New clinical data ...
GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic ...
Although the window for Rhythm Pharmaceuticals’ Imcivree to break out of the genetic obesity realm is quickly approaching ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced three major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results